KOSTER CHRISTOPHER sold $3.8M of CNC

KOSTER CHRISTOPHER (Secretary & General Counsel) sold 56,500 shares of CENTENE CORP (CNC) at $66.90 ($3.78M total) on 2026-08-26.

Original reporting
SEC EDGAR · KOSTER CHRISTOPHER
Published Aug 27, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNC
Neutral
medium confidence
Mentioned
$CNC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNCNeutralLow
01

Why it matters

The sale reduces insider ownership but is unlikely to move the stock significantly.

02

Market read

Provides fresh insider transaction data for traders monitoring CNC.

03

What to watch

Potential upcoming earnings or strategic moves not disclosed.

Relevance 6/10Novelty 6/10Timing: reported after market close on 2026-08-26

Background

Form 4 filing discloses insider transactions to the SEC.

Company-level read

Ticker impact

$CNCNeutralMedium confidence
Context

Officer Christopher Koster sold 56,500 shares for $3.78M, reducing his stake to 248,854 shares.

Expected impact

Potential short-term pressure on CNC stock.

Evidence & confidence

Officer sale of $3.8M is material but not large enough to trigger major price move.

Market effects

Minimal impact on health insurance sector.

None.

None.

Counterpoint

Insider sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Centene Corp

    US-listed health insurer (ticker CNC).

  • Christopher Koster

    Secretary & General Counsel of Centene.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UNHMed

Medicare, Medicaid Overhaul Targets Fraudulent Billing and Unauthorized Marketplace Enrollments

CMS proposed reforms to combat fraud in Medicare, Medicaid, CHIP, and the Health Insurance Marketplace, aiming to save $90B over 10 years. The rule strengthens oversight, requires self-reporting of overpayments, and increases transparency. Managed care stocks fell, including UNH, HUM, CVS, CLOV, CNC, MOH, ELV, and OSCR. Medicare anti-fraud efforts saved $41.9B in 2025, with a $22.30 return per dollar spent.

$CVSMed

11 Medicare Advantage Insurers Sue CMS Over 2027 Star Ratings and Nearly $4 Billion in Payments

Eleven Medicare Advantage insurers, including CVS Health, Elevance Health, and Centene, sued the CMS over 2027 star ratings, claiming nearly $4 billion in potential losses. They argue CMS used unauthorized measures, citing a recent court ruling in Clover Health's favor. Higher ratings affect bonus payments and rebates. CMS is appealing the Clover decision and has not commented on the new lawsuits.

$UNHHighAI 8/10

Positive Medicaid signals, open enrollment trends: Recapping major payers' Q3 results

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

High

Centene Surges 10.5% After Truist Securities Reiterates Buy

Centene Corporation's stock surged 10.5% to $74.56 on Wednesday, with a market cap of $37.3B, after Truist Securities, Wells Fargo, and JP Morgan raised their price targets by an average of 7.4%. Truist maintained a Buy rating, while Wells Fargo and JP Morgan adjusted their targets to $75 with Equal-Weight and Neutral ratings, respectively. The average price target is now $77, indicating potential upside.